Increasing Access to Innovative Medicines
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget…
All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Filter by
Cost Drivers Report 2023
Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic. Read the full report….
Cost of A Private Drug Plan Claim
IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis….
